References
1. Zhang D, Dong Y, Li Y, Chen J, Wang J, Hou L. Efficacy and Safety of
Cerebrolysin for Acute Ischemic Stroke: A Meta-Analysis of Randomized
Controlled Trials. Biomed Res Int. 2017; 2017:4191670.
doi:10.1155/2017/4191670
2. Muresanu, Dafin F., et al. ”Cerebrolysin and Recovery After Stroke
(CARS) A randomized, placebo-controlled, double-blind, multicenter
trial.” Stroke 47.1 (2016): 151-159.
3. Ziganshina LE, Abakumova T, Vernay L. Cerebrolysin for acute ischemic
stroke. Cochrane Database Syst Rev . 2017;4(4):CD007026. Published
2017 Apr 21. doi:10.1002/14651858. CD007026.pub5
4. Gharagozli K, Harandi AA, Houshmand S, et al. Efficacy and safety of
Cerebrolysin treatment in early recovery after acute ischemic stroke: a
randomized, placebo-controlled, double-blinded, multicenter clinical
trial. J Med Life . 2017;10(3):153-160.
5. Bornstein NM, Guekht A, Vester J, et al. Safety and efficacy of
Cerebrolysin in early post-stroke recovery: a meta-analysis of nine
randomized clinical trials. Neurol
Sci . 2018;39(4):629-640. doi:10.1007/s10072-017-3214-0
6. Guekht A, Vester J, Heiss WD, et al. Safety and efficacy of
Cerebrolysin in motor function recovery after stroke: a meta-analysis of
the CARS trials. Neurol Sci . 2017;38(10):1761-1769.
doi:10.1007/s10072-017-3037-z
7. Mekaj YH, Daci FT, Mekaj AY. New insights into the mechanisms of
action of aspirin and its use in the prevention and treatment of
arterial and venous thromboembolism. Ther Clin Risk Manag . 2015;
11:1449-1456. Published 2015 Sep 24. doi:10.2147/TCRM.S92222
8. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L,
Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A,
Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine
MS, Taskinen MR, Tokgozoglu L, Wiklund O; ESC Scientific Document Group.
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid
modification to reduce cardiovascular risk. Eur Heart J. 2020 Jan
1;41(1):111-188. doi: 10.1093/eurheartj/ehz455. PMID: 31504418.
9. Berger C, Stauder A, Xia F, Sommer C, Schwab S (2008) Neuroprotection
and glutamate attenuation by acetylsalicylic acid in temporary but not
in permanent cerebral ischemia. Exp Neurol 210:543–8.
10.1016/j.expneurol.2007.12.002
10. Wei Z, Chigurupati S, Arumugam TV, Jo DG, Li H, Chan SL. Notch
activation enhances the microglia-mediated inflammatory response
associated with focal cerebral ischemia. Stroke .
2011;42(9):2589-2594. doi:10.1161/STROKEAHA.111.614834